Valuation Zhuhai Rundu Pharmaceutical Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 06/11/2026			5-day change	1st Jan Change
9.290 ^CNY	-1.80%		+5.45%	-23.54%

11-06	Zhuhai Rundu Pharmaceutical Secures NMPA Marketing Approval for Vonoprazan Fumarate API	MT
08-20	Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	2,999	4,552	4,186	4,133	3,195	4,069
Change	-	51.79%	-8.03%	-1.28%	-22.69%	27.36%
Enterprise Value (EV) ¹	2,772	4,588	4,433	4,491	3,489	4,345
Change	-	65.48%	-3.37%	1.31%	-22.32%	24.54%
P/E	21.8x	32.2x	26.9x	61.7x	79.5x	-63.9x
PBR	2.89x	4.09x	3.5x	3.5x	2.77x	3.92x
PEG	-	11.9x	2.4x	-1.1x	-2x	0x
Capitalization / Revenue	2.39x	3.83x	3.05x	3.2x	2.7x	3.46x
EV / Revenue	2.21x	3.86x	3.23x	3.48x	2.95x	3.69x
EV / EBITDA	15.6x	23.1x	18.8x	24.5x	20.1x	37.9x
EV / EBIT	21.8x	33.1x	26.7x	62.1x	88.3x	-164x
EV / FCF	-24.5x	-22.2x	-34.3x	-33.4x	27.7x	39.5x
FCF Yield	-4.07%	-4.51%	-2.92%	-2.99%	3.61%	2.53%
Dividend per Share ²	0.2198	0.2198	0.25	0.2	0.15	-
Rate of return	2.48%	1.63%	2%	1.62%	1.57%	-
EPS ²	0.4066	0.4176	0.4643	0.2	0.12	-0.19
Distribution rate	54.1%	52.6%	53.8%	100%	125%	-
Net sales ¹	1,253	1,190	1,372	1,292	1,182	1,176
EBITDA ¹	177.3	198.4	235.5	183.2	173.3	114.6
EBIT ¹	127.3	138.5	166	72.31	39.52	-26.57
Net income ¹	135.9	139.8	155.5	66.9	39.88	-63.47
Net Debt ¹	-226.3	36.22	247.3	358.9	294	276.1
Reference price ²	8.863	13.467	12.500	12.340	9.540	12.150
Nbr of stocks (in thousands)	338,359	337,992	334,893	334,893	334,893	334,893
Announcement Date	22/4/21	18/4/22	27/4/23	27/4/24	28/4/25	27/4/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.	-	-	-	-	466M
ELI LILLY AND COMPANY	39.62x	13.42x	28.51x	0.5%	1,206B
JOHNSON & JOHNSON	40.43x	6.79x	19.09x	1.93%	665B
ABBVIE INC.	37.52x	8.51x	17.57x	2.38%	515B
ROCHE HOLDING AG	20.98x	5.12x	12.74x	2.57%	381B
MERCK & CO., INC.	97.18x	5.94x	25.33x	2.32%	362B
NOVARTIS AG	23.18x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.46x	4.89x	13.77x	1.79%	289B
AMGEN INC.	23.75x	7.3x	13.55x	2.19%	249B
GILEAD SCIENCES, INC.	-39.18x	7.28x	45.82x	1.98%	207B
Average	29.77x	7.24x	21.19x	2.04%	418.02B
Weighted average by Cap.	35.67x	8.55x	21.86x	1.73%